Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lluis Fajas

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Cancers|January 11, 2022
The Intricate Interplay between Cell Cycle Regulators and Autophagy in CancerDorian V Ziegler, Katharina Huber, Lluis Fajas
Cell Division|February 26, 2010
CDK4, pRB and E2F1: connected to insulinLluis Fajas, Emilie Blanchet, Jean-Sébastien Annicotte
Seminars in Cancer Biology|December 22, 2023
Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancerDorian V Ziegler, Kanishka Parashar, Lluis Fajas
Cell Cycle (Georgetown, Tex.)|December 1, 2009
Cell cycle regulators in the control of metabolismEmilie Blanchet, Jean-Sébastien Annicotte, Lluis Fajas
Frontiers in Endocrinology|November 28, 2017
E2F1, a Novel Regulator of MetabolismPierre-Damien Denechaud, Lluis Fajas, Albert Giralt
Bulletin Du Cancer|March 6, 2007
[Role of PPARgamma in the control of prostate cancer growth: a new approach for therapy]Jean-Sébastien Annicotte, Stéphane Culine, Lluis Fajas
Frontiers in Oncology|September 22, 2017
Cancer: Linking Powerhouses to Suicidal BagsLaia Martinez-Carreres, Anita Nasrallah, Lluis Fajas
EMBO Reports|August 20, 2019
Inter-organ communication: a gatekeeper for metabolic healthJudit Castillo-Armengol, Lluis Fajas, Isabel C Lopez-Mejia
Medecine Sciences : M/S|October 21, 2016
[Cell cycle regulators CDK4 and E2F1 control glucose and lipid homeostasis]Pierre-Damien Denechaud, Isabel C Lopez-Mejia, Lluis Fajas
Journal of Lipid Research|July 3, 2003
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phaseLluis Fajas, Stephanie Miard, Michael R Briggs, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Cancers|January 11, 2022
The Intricate Interplay between Cell Cycle Regulators and Autophagy in CancerDorian V Ziegler, Katharina Huber, Lluis Fajas
Cell Division|February 26, 2010
CDK4, pRB and E2F1: connected to insulinLluis Fajas, Emilie Blanchet, Jean-Sébastien Annicotte
Seminars in Cancer Biology|December 22, 2023
Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancerDorian V Ziegler, Kanishka Parashar, Lluis Fajas
Cell Cycle (Georgetown, Tex.)|December 1, 2009
Cell cycle regulators in the control of metabolismEmilie Blanchet, Jean-Sébastien Annicotte, Lluis Fajas
Frontiers in Endocrinology|November 28, 2017
E2F1, a Novel Regulator of MetabolismPierre-Damien Denechaud, Lluis Fajas, Albert Giralt
Bulletin Du Cancer|March 6, 2007
[Role of PPARgamma in the control of prostate cancer growth: a new approach for therapy]Jean-Sébastien Annicotte, Stéphane Culine, Lluis Fajas
Frontiers in Oncology|September 22, 2017
Cancer: Linking Powerhouses to Suicidal BagsLaia Martinez-Carreres, Anita Nasrallah, Lluis Fajas
EMBO Reports|August 20, 2019
Inter-organ communication: a gatekeeper for metabolic healthJudit Castillo-Armengol, Lluis Fajas, Isabel C Lopez-Mejia
Medecine Sciences : M/S|October 21, 2016
[Cell cycle regulators CDK4 and E2F1 control glucose and lipid homeostasis]Pierre-Damien Denechaud, Isabel C Lopez-Mejia, Lluis Fajas
Journal of Lipid Research|July 3, 2003
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phaseLluis Fajas, Stephanie Miard, Michael R Briggs, et al.
Pageof 9